(CHRW) CH Robinson Worldwide - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US12541W2098
Stock: Freight Brokerage, Logistics, Supply Chain, Customs, Produce
Total Rating 62
Risk 79
Buy Signal -0.72
| Risk 5d forecast | |
|---|---|
| Volatility | 35.2% |
| Relative Tail Risk | -18.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.57 |
| Alpha | 65.55 |
| Character TTM | |
|---|---|
| Beta | 0.373 |
| Beta Downside | 0.479 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.51% |
| CAGR/Max DD | 0.74 |
EPS (Earnings per Share)
Revenue
Description: CHRW CH Robinson Worldwide March 05, 2026
CH Robinson Worldwide Inc. provides freight transportation and logistics services globally. The company operates in North American Surface Transportation and Global Forwarding segments. It offers diverse services including truckload, less-than-truckload, and intermodal transportation. These services are fundamental to the global supply chain, facilitating the movement of goods across various modes.
The company also provides customs brokerage and other logistics services such as warehousing and supply chain consulting. Additionally, it operates Robinson Fresh, a segment focused on the buying and selling of perishable goods like fruits and vegetables, serving grocery retailers and restaurants. This diversified approach is common among large logistics providers seeking to offer comprehensive solutions.
CH Robinson Worldwide Inc. was founded in 1905 and is headquartered in Eden Prairie, Minnesota. Further in-depth analysis of CHRWs financials and market position can be found on ValueRay.
Headlines to watch out for
- Freight volume fluctuations impact brokerage revenue
- Fuel price volatility affects transportation costs
- Global trade policies influence forwarding demand
- Economic slowdowns reduce logistics spending
- Regulatory changes in trucking industry increase compliance costs
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 587.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 9.01 > 1.0 |
| NWC/Revenue: 5.96% < 20% (prev 3.64%; Δ 2.32% < -1%) |
| CFO/TA 0.18 > 3% & CFO 914.5m > Net Income 587.1m |
| Net Debt (1.47b) to EBITDA (975.6m): 1.51 < 3 |
| Current Ratio: 1.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (121.7m) vs 12m ago -0.52% < -2% |
| Gross Margin: 8.37% > 18% (prev 0.07%; Δ 830.0% > 0.5%) |
| Asset Turnover: 313.5% > 50% (prev 334.6%; Δ -21.08% > 0%) |
| Interest Coverage Ratio: 6.02 > 6 (EBITDA TTM 975.6m / Interest Expense TTM 145.1m) |
Altman Z'' 8.26
| A: 0.19 (Total Current Assets 2.80b - Total Current Liabilities 1.83b) / Total Assets 5.06b |
| B: 1.20 (Retained Earnings 6.07b / Total Assets 5.06b) |
| C: 0.17 (EBIT TTM 872.8m / Avg Total Assets 5.18b) |
| D: 1.87 (Book Value of Equity 6.01b / Total Liabilities 3.21b) |
| Altman-Z'' Score: 8.26 = AAA |
Beneish M -3.18
| DSRI: 1.06 (Receivables 2.52b/2.58b, Revenue 16.23b/17.72b) |
| GMI: 0.88 (GM 8.37% / 7.38%) |
| AQI: 1.05 (AQ_t 0.37 / AQ_t-1 0.35) |
| SGI: 0.92 (Revenue 16.23b / 17.72b) |
| TATA: -0.06 (NI 587.1m - CFO 914.5m) / TA 5.06b) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of CHRW shares?
As of March 13, 2026, the stock is trading at USD 175.78 with a total of 1,046,069 shares traded.
Over the past week, the price has changed by -6.69%, over one month by +2.78%, over three months by +9.78% and over the past year by +82.07%.
Over the past week, the price has changed by -6.69%, over one month by +2.78%, over three months by +9.78% and over the past year by +82.07%.
Is CHRW a buy, sell or hold?
CH Robinson Worldwide has received a consensus analysts rating of 3.81.
Therefore, it is recommended to buy CHRW.
- StrongBuy: 11
- Buy: 2
- Hold: 11
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the CHRW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 193.5 | 10.1% |
| Analysts Target Price | 193.5 | 10.1% |
CHRW Fundamental Data Overview March 11, 2026
P/E Trailing = 36.3347
P/E Forward = 30.3951
P/S = 1.2851
P/B = 11.696
P/EG = 2.7416
Revenue TTM = 16.23b USD
EBIT TTM = 872.8m USD
EBITDA TTM = 975.6m USD
Long Term Debt = 1.09b USD (from longTermDebt, last quarter)
Short Term Debt = 72.2m USD (from shortTermDebt, last quarter)
Debt = 1.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.47b USD (from netDebt column, last quarter)
Enterprise Value = 22.33b USD (20.86b + Debt 1.63b - CCE 160.9m)
Interest Coverage Ratio = 6.02 (Ebit TTM 872.8m / Interest Expense TTM 145.1m)
EV/FCF = 24.95x (Enterprise Value 22.33b / FCF TTM 894.9m)
FCF Yield = 4.01% (FCF TTM 894.9m / Enterprise Value 22.33b)
FCF Margin = 5.51% (FCF TTM 894.9m / Revenue TTM 16.23b)
Net Margin = 3.62% (Net Income TTM 587.1m / Revenue TTM 16.23b)
Gross Margin = 8.37% ((Revenue TTM 16.23b - Cost of Revenue TTM 14.87b) / Revenue TTM)
Gross Margin QoQ = 8.18% (prev 8.62%)
Tobins Q-Ratio = 4.41 (Enterprise Value 22.33b / Total Assets 5.06b)
Interest Expense / Debt = 0.84% (Interest Expense 13.7m / Debt 1.63b)
Taxrate = 18.14% (30.2m / 166.5m)
NOPAT = 714.5m (EBIT 872.8m * (1 - 18.14%))
Current Ratio = 1.53 (Total Current Assets 2.80b / Total Current Liabilities 1.83b)
Debt / Equity = 0.88 (Debt 1.63b / totalStockholderEquity, last quarter 1.85b)
Debt / EBITDA = 1.51 (Net Debt 1.47b / EBITDA 975.6m)
Debt / FCF = 1.64 (Net Debt 1.47b / FCF TTM 894.9m)
Total Stockholder Equity = 1.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.34% (Net Income 587.1m / Total Assets 5.06b)
RoE = 32.52% (Net Income TTM 587.1m / Total Stockholder Equity 1.81b)
RoCE = 30.15% (EBIT 872.8m / Capital Employed (Equity 1.81b + L.T.Debt 1.09b))
RoIC = 23.35% (NOPAT 714.5m / Invested Capital 3.06b)
WACC = 6.81% (E(20.86b)/V(22.49b) * Re(7.29%) + D(1.63b)/V(22.49b) * Rd(0.84%) * (1-Tc(0.18)))
Discount Rate = 7.29% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.85%
[DCF] Terminal Value 85.23% ; FCFF base≈720.9m ; Y1≈889.2m ; Y5≈1.51b
[DCF] Fair Price = 271.0 (EV 33.62b - Net Debt 1.47b = Equity 32.15b / Shares 118.6m; r=6.81% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -25.56 | EPS CAGR: -12.73% | SUE: 0.60 | # QB: 0
Revenue Correlation: -84.07 | Revenue CAGR: -13.76% | SUE: -0.40 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.53 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+3 | Analysts=23
EPS current Year (2026-12-31): EPS=6.05 | Chg7d=+0.000 | Chg30d=+0.003 | Revisions Net=+5 | Growth EPS=+18.8% | Growth Revenue=+2.2%
EPS next Year (2027-12-31): EPS=7.16 | Chg7d=+0.000 | Chg30d=+0.004 | Revisions Net=+10 | Growth EPS=+18.3% | Growth Revenue=+6.6%
[Analyst] Revisions Ratio: +0.20 (9 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.2% (Discount Rate 7.9% - Earnings Yield 2.8%)
[Growth] Growth Spread = -3.7% (Analyst 1.5% - Implied 5.2%)
P/E Forward = 30.3951
P/S = 1.2851
P/B = 11.696
P/EG = 2.7416
Revenue TTM = 16.23b USD
EBIT TTM = 872.8m USD
EBITDA TTM = 975.6m USD
Long Term Debt = 1.09b USD (from longTermDebt, last quarter)
Short Term Debt = 72.2m USD (from shortTermDebt, last quarter)
Debt = 1.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.47b USD (from netDebt column, last quarter)
Enterprise Value = 22.33b USD (20.86b + Debt 1.63b - CCE 160.9m)
Interest Coverage Ratio = 6.02 (Ebit TTM 872.8m / Interest Expense TTM 145.1m)
EV/FCF = 24.95x (Enterprise Value 22.33b / FCF TTM 894.9m)
FCF Yield = 4.01% (FCF TTM 894.9m / Enterprise Value 22.33b)
FCF Margin = 5.51% (FCF TTM 894.9m / Revenue TTM 16.23b)
Net Margin = 3.62% (Net Income TTM 587.1m / Revenue TTM 16.23b)
Gross Margin = 8.37% ((Revenue TTM 16.23b - Cost of Revenue TTM 14.87b) / Revenue TTM)
Gross Margin QoQ = 8.18% (prev 8.62%)
Tobins Q-Ratio = 4.41 (Enterprise Value 22.33b / Total Assets 5.06b)
Interest Expense / Debt = 0.84% (Interest Expense 13.7m / Debt 1.63b)
Taxrate = 18.14% (30.2m / 166.5m)
NOPAT = 714.5m (EBIT 872.8m * (1 - 18.14%))
Current Ratio = 1.53 (Total Current Assets 2.80b / Total Current Liabilities 1.83b)
Debt / Equity = 0.88 (Debt 1.63b / totalStockholderEquity, last quarter 1.85b)
Debt / EBITDA = 1.51 (Net Debt 1.47b / EBITDA 975.6m)
Debt / FCF = 1.64 (Net Debt 1.47b / FCF TTM 894.9m)
Total Stockholder Equity = 1.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.34% (Net Income 587.1m / Total Assets 5.06b)
RoE = 32.52% (Net Income TTM 587.1m / Total Stockholder Equity 1.81b)
RoCE = 30.15% (EBIT 872.8m / Capital Employed (Equity 1.81b + L.T.Debt 1.09b))
RoIC = 23.35% (NOPAT 714.5m / Invested Capital 3.06b)
WACC = 6.81% (E(20.86b)/V(22.49b) * Re(7.29%) + D(1.63b)/V(22.49b) * Rd(0.84%) * (1-Tc(0.18)))
Discount Rate = 7.29% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.85%
[DCF] Terminal Value 85.23% ; FCFF base≈720.9m ; Y1≈889.2m ; Y5≈1.51b
[DCF] Fair Price = 271.0 (EV 33.62b - Net Debt 1.47b = Equity 32.15b / Shares 118.6m; r=6.81% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -25.56 | EPS CAGR: -12.73% | SUE: 0.60 | # QB: 0
Revenue Correlation: -84.07 | Revenue CAGR: -13.76% | SUE: -0.40 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.53 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+3 | Analysts=23
EPS current Year (2026-12-31): EPS=6.05 | Chg7d=+0.000 | Chg30d=+0.003 | Revisions Net=+5 | Growth EPS=+18.8% | Growth Revenue=+2.2%
EPS next Year (2027-12-31): EPS=7.16 | Chg7d=+0.000 | Chg30d=+0.004 | Revisions Net=+10 | Growth EPS=+18.3% | Growth Revenue=+6.6%
[Analyst] Revisions Ratio: +0.20 (9 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.2% (Discount Rate 7.9% - Earnings Yield 2.8%)
[Growth] Growth Spread = -3.7% (Analyst 1.5% - Implied 5.2%)